AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing

References

• Miyamoto S. Autophagy and cardiac aging. Cell Death Differ. 2019;26(4):653–664.
   PubMed Web of Science ®Google Scholar
• Quarles EK, Dai DF, Tocchi A, et al. Quality control systems in cardiac aging. Ageing Res Rev. 2015;23(Pt A):101–115.
   PubMed Web of Science ®Google Scholar
• Lakatta EG. So! what’s aging? Is cardiovascular aging a disease? J Mol Cell Cardiol. 2015;83:1–13.
   PubMed Web of Science ®Google Scholar
• Dai DF, Rabinovitch PS. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med. 2009;19(7):213–220.
   PubMed Web of Science ®Google Scholar
• Murtha LA, Schuliga MJ, Mabotuwana NS, et al. The processes and mechanisms of cardiac and pulmonary fibrosis. Front Physiol. 2017;8(777):777.
   PubMed Web of Science ®Google Scholar
• Meschiari CA, Ero OK, Pan H, et al. The impact of aging on cardiac extracellular matrix. Geroscience. 2017;39(1):7–18.
   PubMed Web of Science ®Google Scholar
• Sawaki D, Czibik G, Pini M, et al. Visceral adipose tissue drives cardiac aging through modulation of fibroblast senescence by osteopontin production. Circulation. 2018;138(8):809–822.
   PubMed Web of Science ®Google Scholar
• Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4(1):44–52.
   PubMed Web of Science ®Google Scholar
• Meador BM, Krzyszton CP, Johnson RW, et al. Effects of IL-10 and age on IL-6, IL-1beta, and TNF-alpha responses in mouse skeletal and cardiac muscle to an acute inflammatory insult. J Appl Physiol. 2008;104(4):991–997.
   PubMed Web of Science ®Google Scholar
• Marin-Aguilar F, Lechuga-Vieco AV, Alcocer-Gomez E, et al. NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice. Aging Cell. 2020;19(1):e13050.
   PubMed Web of Science ®Google Scholar
• Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2001;104(7):826–831.
   PubMed Web of Science ®Google Scholar
• Chiao YA, Dai Q, Zhang J, et al. Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ Cardiovasc Genet. 2011;4(4):455–462.
   PubMedGoogle Scholar
• Zhou Z, Wang J, Song Y, et al. Panax notoginseng saponins attenuate cardiomyocyte apoptosis through mitochondrial pathway in natural aging rats. Phytother Res. 2018;32(2):243–250.
   PubMed Web of Science ®Google Scholar
• Song YN, Yuan D, Zhang CC, et al. Effect of saponins extracted from panax japonicus on inhibiting cardiomyocyte apoptosis by AMPK/Sirt1/NF-kappaB signaling pathway in aging rats. Zhongguo Zhong Yao Za Zhi. 2017;42(23):4656–4660.
   PubMedGoogle Scholar
• Song YN, Wang LP, Zheng J, et al. Effect of saponins extracted from panax japonicas on inhibiting myocardial fibrosis by TGF-beta1/Smad3 signaling pathway in aging rats. Zhongguo Zhong Yao Za Zhi. 2018;43(22):4513–4518.
   PubMedGoogle Scholar
• Han L, Li M, Liu Y, et al. Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats. Pharmacology. 2012;89(1-2):74–82.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–663.
   PubMed Web of Science ®Google Scholar
• Sun SC, Ley SC. New insights into NF-kappaB regulation and function. Trends Immunol. 2008;29(10):469–478.
   PubMed Web of Science ®Google Scholar
• Chen Z, Amro EM, Becker F, et al. Cohesin-mediated NF-kappaB signaling limits hematopoietic stem cell self-renewal in aging and inflammation. J Exp Med. 2019;216(1):152–175.
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Papismadov N, et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. Embo J. 2017;36(15):2280–2295.
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493(7432):346–355.
   PubMed Web of Science ®Google Scholar
• Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med. 2011;89(7):667–676.
   PubMed Web of Science ®Google Scholar
• Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev. 2012;11(2):230–241.
   PubMed Web of Science ®Google Scholar
• Sung MM, Das SK, Levasseur J, et al. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism. Circ: Heart Failure. 2015;8(1):128–137.
   PubMed Web of Science ®Google Scholar
• Beauloye C, Bertrand L, Horman S, et al. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res. 2011;90(2):224–233.
   PubMed Web of Science ®Google Scholar
• Cieslik KA, Taffet GE, Crawford JR, et al. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J Mol Cell Cardiol. 2013;63:26–36.
   PubMed Web of Science ®Google Scholar
• Chang C, Su H, Zhang D, et al. AMPK-dependent phosphorylation of GAPDH triggers Sirt1 activation and is necessary for autophagy upon glucose starvation. Mol Cell. 2015;60(6):930–940.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang X, He Y, et al. The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1. PLoS One. 2012;7(11):e49935.
   PubMed Web of Science ®Google Scholar
• Zhang T, Hu J, Wang X, et al. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappaB-TNFalpha pathway. J Hepatol. 2019;70(1):87–96.
   PubMed Web of Science ®Google Scholar
• de Gregorio E, Colell A, Morales A, et al. Relevance of SIRT1-NF-κB axis as therapeutic target to ameliorate inflammation in liver disease. IJMS. 2020;21(11):3858.
   Web of Science ®Google Scholar
• Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539–2550.
   PubMed Web of Science ®Google Scholar
• Soori R, Amini AA, Choobineh S, et al. Exercise attenuates myocardial fibrosis and increases angiogenesis-related molecules in the myocardium of aged rats. Arch Physiol Biochem. 2022;128(1):1–6.
   PubMed Web of Science ®Google Scholar
• Wang JH, Zhao L, Pan X, et al. Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-beta1 signaling pathway. Lab Invest. 2016;96(9):1035.
   PubMed Web of Science ®Google Scholar
• Travers JG, Kamal FA, Robbins J, et al. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118(6):1021–1040.
   PubMed Web of Science ®Google Scholar
• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549–574.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Nishida K, Otsu K. Macromolecular degradation systems and cardiovascular aging. Circ Res. 2016;118(10):1577–1592.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Rai R, Flevaris P, et al. Epigenetics in reactive and reparative cardiac fibrogenesis: the promise of epigenetic therapy. J Cell Physiol. 2017;232(8):1941–1956.
   PubMed Web of Science ®Google Scholar
• Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106(11):1675–1680.
   PubMed Web of Science ®Google Scholar
• Kakkar R, Lee RT. Intramyocardial fibroblast myocyte communication. Circ Res. 2010;106(1):47–57.
   PubMed Web of Science ®Google Scholar
• Kurose H, Mangmool S. Myofibroblasts and inflammatory cells as players of cardiac fibrosis. Arch Pharm Res. 2016;39(8):1100–1113.
   PubMed Web of Science ®Google Scholar
• Guo Y, Gupte M, Umbarkar P, et al. Entanglement of GSK-3beta, beta-catenin and TGF-beta1 signaling network to regulate myocardial fibrosis. J Mol Cell Cardiol. 2017;110:109–120.
   PubMed Web of Science ®Google Scholar
• He H, Xu P, Zhang X, et al. Aging-induced IL27Ra signaling impairs hematopoietic stem cells. Blood. 2020;136(2):183–198.
   PubMed Web of Science ®Google Scholar
• Darband SG, Sadighparvar S, Yousefi B, et al. Combination of exercise training and L-arginine reverses aging process through suppression of oxidative stress, inflammation, and apoptosis in the rat heart. Pflugers Arch. 2020;472(2):169–178.
   PubMed Web of Science ®Google Scholar
• Chen J, Fan J, Wang S, et al. Secreted klotho attenuates inflammation-associated aortic valve fibrosis in senescence-accelerated mice P1. Hypertension. 2018;71(5):877–885.
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112.
   PubMed Web of Science ®Google Scholar
• Aragon-Herrera A, Feijoo-Bandin S, Otero Santiago M, et al. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats. Biochem Pharmacol. 2019;170:113677.
   PubMed Web of Science ®Google Scholar
• Natoli G. When sirtuins and NF-kappaB collide. Cell. 2009;136(1):19–21.
   PubMed Web of Science ®Google Scholar
• Jimi E, Takakura N, Hiura F, et al. The role of NF-kappaB in physiological bone development and inflammatory bone diseases: is NF-kappaB inhibition “killing two birds with one stone”? Cells. 2019;8(12):1636.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang L, Lu A, et al. ATM is a key driver of NF-kappaB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging. Aging. 2020;12(6):4688–4710.
   PubMedGoogle Scholar
• Zannas AS, Jia M, Hafner K, et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-kappaB-driven inflammation and cardiovascular risk. Proc Natl Acad Sci U S A. 2019;116(23):11370–11379.
   PubMed Web of Science ®Google Scholar
• Gao ZQ, Yang C, Wang YY, et al. RAGE upregulation and nuclear factor-kappaB activation associated with ageing rat cardiomyocyte dysfunction. Gen Physiol Biophys. 2008;27(3):152–158.
   PubMed Web of Science ®Google Scholar
• Sun B, Xia Q, Gao Z. Total flavones of Choerospondias axillaris attenuate cardiac dysfunction and myocardial interstitial fibrosis by modulating NF-kappaB signaling pathway. Cardiovasc Toxicol. 2015;15(3):283–289.
   PubMed Web of Science ®Google Scholar
• Cao L, Liu C, Wang F, et al. SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-kappaB pathway. Braz J Med Biol Res. 2013;46(8):659–669.
   PubMed Web of Science ®Google Scholar